Related Experiment Videos

Limitations of current HIV therapies: opportunities for improvement

William G Powderly¹

¹Washington University School of Medicine, St. Louis, Missouri, USA.

Journal of Acquired Immune Deficiency Syndromes (1999)

|August 30, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A Multistate Analysis of Longitudinal Care Outcomes Among People Newly Linked to Human Immunodeficiency Virus Care in Missouri.

Open forum infectious diseases·2026

Mapping the Geographic Distribution of Dimorphic Mycoses Using a US Commercial Insurance Database.

Open forum infectious diseases·2025

Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM).

Journal of clinical pharmacology·2025

SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial.

Therapeutic advances in infectious disease·2025

Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis.

CHEST critical care·2024

Antiretroviral Therapy and Cardiovascular Risk in People With HIV in the United States-An Updated Analysis.

Open forum infectious diseases·2024

See all related articles